Alan Schafer to head Population Genetics

07-May-2012 - United Kingdom

Population Genetics Technologies Ltd. has appointed Alan Schafer, PhD to the post of Chief Executive Officer.

Schafer brings deep experience in research, “big pharma” management and building new businesses. He is Adjunct Professor of Innovation at Imperial College London Business School and was previously the Wellcome Trust’s Director of Science Funding. Before that he served as Global Vice-President of Technology Development at GlaxoSmithKline and co-founded Hexagen, a functional genomics company and subsequently acquired by Incyte. He will continue to serve on a number of research and venture capital advisory boards.

Other news from the department people

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy